Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.

Elias D, Goéré D, Leroux G, Dromain C, Leboulleux S, de Baere T, Ducreux M, Baudin E.

Eur J Surg Oncol. 2009 Oct;35(10):1092-7. doi: 10.1016/j.ejso.2009.02.017. Epub 2009 May 21.

PMID:
19464140
2.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
3.

[Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].

Auernhammer CJ, Jauch KW, Hoffmann JN.

Zentralbl Chir. 2009 Sep;134(5):410-7. doi: 10.1055/s-0029-1224607. Epub 2009 Sep 15. Review. German.

PMID:
19757340
4.

Interventional treatment of neuroendocrine liver metastases.

Knigge U, Hansen CP, Stadil F.

Surgeon. 2008 Aug;6(4):232-9. Review.

PMID:
18697366
5.

A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D.

Eur J Cancer. 2009 Jul;45(10):1748-56. doi: 10.1016/j.ejca.2009.03.012. Epub 2009 Apr 6. Review.

PMID:
19356924
6.

The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas.

Hodul P, Malafa M, Choi J, Kvols L.

Cancer Control. 2006 Jan;13(1):61-71. Review.

7.

Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.

Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y.

Dig Surg. 2008;25(6):445-60. doi: 10.1159/000184736. Epub 2009 Feb 12. Review.

PMID:
19212117
8.

[Indications and operative procedures for neuroendocrine liver metastases].

Musholt TJ, Lang H.

Chirurg. 2009 Feb;80(2):113-21. doi: 10.1007/s00104-008-1614-7. Review. German.

PMID:
19212693
9.

[Surgical prospects for liver metastases].

Vennarecci G, Ettorre GM, Lorusso R, Santoro R, Visco G, Santoro E.

Chir Ital. 2007 Jan-Feb;59(1):27-39. Review. Italian.

PMID:
17361929
10.

Review article: Multimodality treatment of liver metastases increases suitability for surgical treatment.

de Jong KP.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:161-9. doi: 10.1111/j.1365-2036.2007.03484.x. Review.

11.

Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors.

Que FG, Sarmiento JM, Nagorney DM.

Cancer Control. 2002 Jan-Feb;9(1):67-79. Review. No abstract available.

PMID:
11907468
12.

Radiofrequency ablation of primary and metastatic hepatic malignancies.

Hanna NN.

Clin Colorectal Cancer. 2004 Jul;4(2):92-100. Review.

PMID:
15285816
13.

Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review.

Bonaccorsi-Riani E, Apestegui C, Jouret-Mourin A, Sempoux C, Goffette P, Ciccarelli O, Borbath I, Hubert C, Gigot JF, Hassoun Z, Lerut J.

Transpl Int. 2010 Jul;23(7):668-78. doi: 10.1111/j.1432-2277.2010.01086.x. Epub 2010 May 5. Review.

14.

Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS).

Boudreaux JP.

Endocrinol Metab Clin North Am. 2011 Mar;40(1):163-71, ix. doi: 10.1016/j.ecl.2010.12.004. Review.

PMID:
21349417
15.

Hepatic ablation for neuroendocrine tumor metastases.

Maithel SK, Fong Y.

J Surg Oncol. 2009 Dec 15;100(8):635-8. doi: 10.1002/jso.21196. Review.

PMID:
20017158
16.

Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).

Ye YJ, Gao ZD, Poston GJ, Wang S.

Eur J Surg Oncol. 2009 Aug;35(8):787-92. doi: 10.1016/j.ejso.2009.01.003. Epub 2009 Jan 29. Review.

PMID:
19185444
17.

Liver resection combined with local ablation: where are the limits?

de Jong KP, Wertenbroek MW.

Dig Surg. 2011;28(2):127-33. doi: 10.1159/000323823. Epub 2011 Apr 29. Review.

PMID:
21540598
18.

Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.

Norton JA.

Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):577-83. Review.

PMID:
16183528
19.

Actual role of radiofrequency ablation of liver metastases.

Pereira PL.

Eur Radiol. 2007 Aug;17(8):2062-70. Epub 2007 Feb 15. Review.

PMID:
17429644
20.

Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.

Zappa M, Abdel-Rehim M, Hentic O, Vullierme MP, Ruszniewski P, Vilgrain V.

Target Oncol. 2012 Jun;7(2):107-16. doi: 10.1007/s11523-012-0219-8. Epub 2012 May 22. Review.

PMID:
22707276

Supplemental Content

Support Center